Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


SpinLaunch turns to existing investors for $35m
GV and Airbus Ventures returned for a round that lifted the kinetic-energy launch technology developer's total funding to $80m.
Gathered Foods nets $32m
Greenleaf Foods invested $5m in the fish substitute producer as part of a series B round that included General Mills' corporate venturing subsidiary, 301.
ActionIQ packs $32m into series C round
Cisco reportedly took part in a round that boosted the overall funding for the Shutterstock-backed enterprise data management platform to $75m.
KeyMe admits another $35m
Brentwood Associates led a round that will fund US expansion by the Comcast and 7-Eleven-backed digital locksmith along with an expansion of its services.
Cigna Ventures signs off on two new deals
Cigna's corporate venturing arm led a $29.5m round for population healthcare management platform and bumped Buoy Health's series B up to $20m.
Vesta Healthcare rests series A with $30m
CareCentrix, Nationwide and existing backer Kaiser Permanente all chipped in as the homecare support services provider secured $30m.
Fusion Pharmaceuticals fetches $20m
Canada Pension Plan Investment Board has pledged up to $20m for the Varian Medical and Johnson & Johnson-backed oncology drug developer.
ReadCoor scores $27m series B
Eli Lilly-backed ReadCoor took its total funding to $50m and will use the funding to commercialise its gene sequencing technology.

Other News

Corvus uncorks $32m series B round
Proceeds from the Telstra Ventures-led series B round will allow Corvus to accelerate insurance technology development and build tools to improve its risk management.
Novome navigates $33m series A round
Mayo Clinic has bet on chronic disease drug developer Novome Biotechnologies, which is initially targeting a disorder known as hyperoxaluria.
Line helps TimeBank clock up funding
Line Ventures backed a $36.2m round for AI-equipped e-commerce platform TimeBank that will help the startup acquire new users and partners.
GNS Healthcare gees up series D to $28m
The medical data analytics platform has raised $5m from Merck Global Health Innovation Fund, adding to $23m raised last year.
VectivBio selects Novo for $35m round
Novo took part in the first round for VectivBio, a short bowel syndrome treatment developer launched out of genetic disease drug developer Therachon.
Virtual Incision sews up $20m in funding
The colectomy-focused surgical device developer, which counts SinoPharm as an earlier investor, has secured series B-plus funding, in a round led by Bluestem Capital.

Editor's Picks

Sub-$50m Investment of the Year: Maana
Maana recently won GCV’s inaugural award for energy-tech corporate venture capital (CVC) investment of the year, presented during its Venture Houston conference in November. Now, Maana has gone one-stage further and won the Sub-$50m Investment of the Year award across all industries.
Intel spreads $72m across 12 companies
Intel Capital has revealed investments in 12 US or China-based portfolio companies and a partnership with the NBA.
The Big Deal: Straightening the clouds
test reg